7 Drugs Approved for Primary Care: Q4 2024
An oral antibiotic for drug-resistant UTIs, a long-awaited therapy for congenital adrenal hyperplasia, and more.
The fourth quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US FDA for conditions that are often seen in primary care. In the slides above, find details on a new treatment for obstructive sleep apnea in patients with obesity, an oral antibiotic for drug-resistant urinary tract infections, a long-awaited therapy for congenital adrenal hyperplasia, and 4 more.
For more information on key FDA approvals from 2024, check out:
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
